{"text": "essential to monitor patients closely for signs of thromboembolic events,\n\nweight gain, metabolic changes, liver function abnormalities, and other\n\npotential side effects (WHO). Regular monitoring and management by a\n\nhealthcare provider can help mitigate these risks and ensure the safe use of\n\nantipsychotics in conjunction with hormonal contraceptives.\n\nReferences:\n\n[1] Journal of Clinical Psychopharmacology, \"Antipsychotic medications and\n\nrisk of thromboembolism\" (https://www.ncbi.nlm.nih.gov/pmc/articles/\n\nPMC4441113/)", "embedding": []}